Gotham Asset Management LLC bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 44,419 shares of the company's stock, valued at approximately $1,031,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Murphy & Mullick Capital Management Corp purchased a new stake in Option Care Health in the 4th quarter valued at approximately $26,000. UMB Bank n.a. boosted its holdings in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after purchasing an additional 346 shares during the last quarter. Signaturefd LLC boosted its holdings in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC boosted its holdings in shares of Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after purchasing an additional 1,099 shares during the last quarter. Finally, Johnson Financial Group Inc. acquired a new stake in shares of Option Care Health during the fourth quarter worth $47,000. Hedge funds and other institutional investors own 98.05% of the company's stock.
Option Care Health Stock Down 1.1%
NASDAQ:OPCH traded down $0.36 during mid-day trading on Wednesday, hitting $32.71. The company had a trading volume of 2,427,078 shares, compared to its average volume of 1,854,698. The business has a fifty day simple moving average of $33.09 and a 200-day simple moving average of $29.15. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The firm has a market capitalization of $5.36 billion, a price-to-earnings ratio of 27.49, a PEG ratio of 2.30 and a beta of 0.76.
Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same period last year, the company posted $0.26 earnings per share. The firm's revenue was up 16.3% compared to the same quarter last year. Equities analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
OPCH has been the topic of several analyst reports. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and raised their price objective for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Barrington Research restated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a report on Wednesday, April 30th. JMP Securities restated a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a report on Tuesday, April 22nd. JPMorgan Chase & Co. raised their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Finally, UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, Option Care Health currently has an average rating of "Moderate Buy" and an average target price of $35.50.
Get Our Latest Stock Analysis on Option Care Health
Insider Buying and Selling at Option Care Health
In other news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.64% of the stock is currently owned by corporate insiders.
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.